FDA Device recall Z-2481-2021
BOND Ready-To-Use Primary Antibody CDX2 (EP25), REF PA0375
- FDA Device
- Class II
- terminated
- Published 2021-09-22
On 2021-09-22 the FDA classified a Class II recall of BOND Ready-To-Use Primary Antibody CDX2 (EP25), REF PA0375 by Leica Microsystems, citing product may not perform as specified in IFU.
Read the official FDA Device notice
| Agency | FDA Device |
|---|---|
| Recall number | Z-2481-2021 |
| Classification | Class II |
| Status | terminated |
| Initiated | 2021-07-30 |
| Published | 2021-09-22 |
| Last updated | 2026-09-13 11:56 UTC |
| Company | Leica Microsystems |
| Distribution | US |
Product
BOND Ready-To-Use Primary Antibody CDX2 (EP25), REF PA0375
Reason
Product may not perform as specified in IFU.
Identifiers
| code_info | Product Code PA0375, Lot 69909 |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:56 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-2481-2021%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.